Surmodics (SRDX)
(Delayed Data from NSDQ)
$41.10 USD
-0.01 (-0.02%)
Updated Aug 9, 2024 04:00 PM ET
After-Market: $41.07 -0.03 (-0.07%) 7:58 PM ET
2-Buy of 5 2
C Value A Growth D Momentum B VGM
Brokerage Reports
Surmodics, Inc. [SRDX]
Reports for Purchase
Showing records 281 - 300 ( 418 total )
Company: Surmodics, Inc.
Industry: Medical - Products
Company: Surmodics, Inc.
Industry: Medical - Products
Company: Surmodics, Inc.
Industry: Medical - Products
Company: Surmodics, Inc.
Industry: Medical - Products
Q2 well ahead of estimates - DCB trial begins - ''''whole products'''' strategy on track
Provider: Feltl & Company
Analyst: HAYNOR B
Company: Surmodics, Inc.
Industry: Medical - Products
Company: Surmodics, Inc.
Industry: Medical - Products
Company: Surmodics, Inc.
Industry: Medical - Products
Company: Surmodics, Inc.
Industry: Medical - Products
Company: Surmodics, Inc.
Industry: Medical - Products
Company: Surmodics, Inc.
Industry: Medical - Products
Company: Surmodics, Inc.
Industry: Medical - Products
Company: Surmodics, Inc.
Industry: Medical - Products
First enrollment in SurVeil drug-coated balloon study, reiterate STRONG BUY
Provider: Feltl & Company
Analyst: HAYNOR B
Company: Surmodics, Inc.
Industry: Medical - Products
Company: Surmodics, Inc.
Industry: Medical - Products
Company: Surmodics, Inc.
Industry: Medical - Products
Company: Surmodics, Inc.
Industry: Medical - Products
Q1 well ahead of estimates - "whole products" strategy potentially massive
Provider: Feltl & Company
Analyst: HAYNOR B
Company: Surmodics, Inc.
Industry: Medical - Products
Company: Surmodics, Inc.
Industry: Medical - Products
Provides updated guidance following Creagh Medical acquisition
Provider: Feltl & Company
Analyst: HAYNOR B